Advanced Micro Devices' competition heats up after a recent partnership between Nvidia and Intel.In today's video, I discuss recent updates impacting Advanced Micro Devices (AMD 0.12%), Intel (INTC 8.82%), Nvidia (NVDA 0.35%), and other semiconductor stocks. To learn more, check out the short video, consider subscribing, and click the special offer link below.*Stock prices used were the post-market prices of Sept. 24, 2025. The video was published on Sept. 24, 2025. ...

The U.S. government may take a 10% equity stake in this domestic lithium producer -- but dilution concerns clash with the de-risked path to 2028 production.The Trump administration wants to own a piece of Lithium Americas (LAC 22.63%), and Wall Street can't decide if that's brilliant or terrifying. The stock spiked this week on reports that the U.S. government is negotiating a 5% to 10% equity stake tied to restructuring the company's $2.26 billion Department of Energy (DOE) loan. Add General Motors' $945 m ...

Schwab U.S. Dividend Equity ETF offers an attractive yield and a unique investment approach that could serve you well for the rest of your life.Stocks in the S&P 500 (^GSPC -0.50%) yield an average of roughly 1.2% today. That makes the 3.6% yield of Schwab U.S. Dividend Equity ETF (SCHD -0.55%) look downright huge. But the attractive yield on offer from this dividend-focused exchange-traded fund (ETF) is just the start of the story. Here's why this somewhat complicated ETF could set you up for a lifetime of ...

When Coleman's Tiger Global Management buys 4 million shares of anything, it's good to pay attention.If I asked you to name a famous billionaire, I'm guessing Chase Coleman III wouldn't be the first one that comes to mind. But in the hedge fund world, he's practically royalty.Coleman is one of the "tiger cubs" who worked for Julian Robertson's Tiger Fund -- the first hedge fund ever -- and then went on to start his own. Today, Coleman's Tiger Global Management fund manages more than $34 billion in securitie ...

BigBear.ai is bigger than both of these AI-focused companies now. That could change.BigBear.ai (BBAI -6.00%) has taken investors on a rollercoaster ride in 2025. The good news, though, is that they're probably enjoying the ride these days. Shares of the artificial intelligence (AI) software company are up more than 70% year to date.Will BigBear.ai's momentum continue? Maybe. However, I think investors can do better. I predict that two stocks will be worth more than BigBear.ai five years from now. 1. Diebold ...

股票表现 - Figma股票在7月31日首次公开上市首日上涨250% [1] - 自8月1日起股价下跌52% [2] - 第二季度财报表现疲软 增长放缓迹象导致投资者担忧 [2] 分析师预期 - 11位分析师给出69美元12个月目标价 较当前水平潜在上涨17% [5] - 华尔街最高目标价85美元 潜在涨幅44% [5] - 仅4位分析师建议买入 其余7位持有评级 [5] 估值水平 - 市销率达到32倍 远期市盈率153倍 [6] - 估值显著高于美国科技行业平均9倍市销率和51倍市盈率 [7] - 当前估值水平与公司财务表现不匹配 [6][7] 财务指标 - 第三季度收入增长指引33% 低于第二季度41%的同比增长 [8] - 预计全年增长37% 收入略超10亿美元 [8] - 高价值客户净美元留存率从2023年第一季159%下降至最近季度129% [9] - ARR超1万美元客户数量增长31% 低于去年同期42%的增幅 [10] 增长前景 - 分析师预计明年收入增长将放缓至23% [11] - 预计净利润下降29% [11] - 人工智能和可观目标市场可能带来增长动力 [10] - 12个月最低目标价49美元 潜在下跌16% [12]

The quantum computing company has a bright future in the defense sector.Quantum computing and defense stocks attract different types of investors. Pure-play quantum computing companies -- which are often unprofitable and trading at sky-high valuations -- tend to attract growth-oriented investors. Big defense companies are usually profitable, but they grow at a slower rate and are more appealing to value investors.However, these two industries are converging as some top quantum computing companies expand int ...

Is this the next meme stock?Opendoor Technologies (OPEN 10.27%) has taken the market by storm in the last three months. The online home flipper gained traction as a meme stock back in July after hedge fund manager Eric Jackson made the argument online that the stock, which was trading at just around $0.50/share, could be the next Carvana, referring to the online used car dealer that jumped more than 100 times after nearly going bankrupt in 2022.Opendoor picked up steam as retail investors piled into the sto ...

Investors might hesitate to buy a stock after such a massive run-up -- but don't let that scare you off.Finally! 2025 appears to be the year QuantumScape (QS 0.28%) investors have long waited for, the moment when the market appreciates what the company is doing and sends its valuation soaring.QuantumScape's stock price has soared 160% higher year to date on enthusiasm about the company producing solid-state lithium-metal batteries that excel in five crucial metrics: energy density, charging speed, safety, l ...

试验结果概述 - 礼来公司发布头对头试验顶线结果 声称其口服GLP-1药物orforglipron在治疗2型糖尿病方面优于诺和诺德口服版Wegovy [2] - 试验主要终点为降低A1C水平（血糖指标） 礼来36mg剂量组A1C降低2.2% 诺和诺德14mg剂量组降低1.4% [3] - 次要终点体重减轻数据显示 礼来36mg剂量组平均减重9.2% 诺和诺德14mg剂量组减重5.3% [4] 数据背景分析 - 诺和诺德正在试验更高剂量25mg口服司美格鲁肽用于肥胖症治疗 远超礼来试验采用的14mg剂量 [4] - 诺和诺德Oasis 4三期试验显示 25mg剂量口服司美格鲁肽实现平均体重减少16.6% [6] - 礼来试验结果不能证明orforglipron在利润更丰厚的肥胖适应症疗效上优于口服司美格鲁肽 [7] 行业竞争态势 - 两种口服药物均未上市销售 试验结果不代表竞争格局已定 [2] - 头对头试验主要针对2型糖尿病治疗 肥胖症适应症存在不同剂量方案 [3][4][7]